A Prospective Evaluation of a Prescription Digital Therapeutic for Treatment of Overactive Bladder in Women: The RiSolve Trial

Inclusion Criteria

Inclusion Criteria: * Adult women aged 18 and older with bothersome OAB symptoms: (i.e. must answer YES to one of the following): * Do you have a sudden need to rush to the toilet to urinate that is bothersome? OR * Does urine leak before you can get to the toilet? * Fluency and literacy in English to enable them to understand and complete treatment and required assessments * Currently based in the Republic of Ireland * Ownership and use of a smartphone * Use of at least one mobile App * Willing to forego commencing any other OAB treatments outside of RiSolve for the trial treatment period. Exclusion Criteria: * Current use of an anticholinergic/beta-agonist, within the previous two weeks and/or at the date of consenting * Currently using intermittent or indwelling catheter * Currently pregnant or planning pregnancy during the study treatment period * Currently receiving treatment for bladder/urethral, colon/anal, or cervical cancer * Voiding dysfunction (i.e. if Yes is an answer to any of the following): * Do you have pain in your bladder? OR * Do you have to strain to urinate? * Currently using sacral or tibial neuromodulation. * Has had intradetrusor therapy * Currently taking antibiotics/drugs for urinary tract infection * Planning surgery for pelvic organ prolapse within the trial treatment period * Planning to undergo pessary fitting during the study period (Note: patients with an existing pessary are eligible) within the trial treatment period * Visual impairment such that in the opinion of the PI would impair their use of the app